Skip to main content
Year archive

Silence Therapeutics plc — 2017 filings

All 15 regulatory filings released by Silence Therapeutics plc (SLN) in 2017, sourced directly from the official regulator.

15 Filings
2017 Period
2017 filings (15)
Filing Released Lang
CEO Ali Mortazavi appointed Chairman of Ultromics
Regulatory Filings
2017-07-14 English
IP update
Regulatory Filings
2017-07-10 English
Issue of claim in the UK High Courts
Regulatory Filings
2017-07-03 English
Change of Adviser
Regulatory Filings
2017-07-03 English
Holding(s) in Company
Major Shareholding Notification
2017-06-29 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2017-06-06 English
Hiring of Chief Operating Officer
Board/Management Information
2017-06-01 English
Silence Continued Expansion of IP
Regulatory Filings
2017-05-30 English
Significant Expansion of Intellectual Property
Investor Presentation
2017-05-16 English
Notice of AGM and Publication of Annual Report
Report Publication Announcement
2017-05-04 English
Silence Therapeutics Presents New Data
Regulatory Filings
2017-05-03 English
Additional Listing
Share Issue/Capital Change
2017-04-12 English
Grant of Share Options to Directors
Director's Dealing
2017-04-03 English
Preliminary Results for the year to 31 Dec 2016
Earnings Release FY 2016
2017-03-28 English
Notice of Results
Report Publication Announcement
2017-03-08 English